We performed meta-analysis using a random-effects model to calculate risk ratios (RRs) and 95% confidence intervals (CIs)
Glucose tolerance tests were performed as previously described [27]
Results from recent trials have demonstrated notably greater reductions in body weight, as illustrated below in the SURMOUNT-3 Phase 3 trial with 25% weight reduction among subjects with GLP-1/GIP and engaged in intensive lifestyle intervention
Briefly, PWA mice were individually placed in the metabolic cages 24 h prior to initiation of the experiment to allow for an adaptation period
Prescribing them fits within an integrative psychopharmacology framework that takes seriously the interconnections between metabolic and mental health
This work was supported by the National Natural Science Foundation of China (81790640, 32070989, 31872766, 31571075, 82070993, and 31571072), the Ministry of Science and Technology of China (2011CB504602 and 2015AA020512), Shanghai Municipal Science and Technology Major Project (2018SHZDZX01), ZJLab, Shanghai Center for Brain Science and Brain-Inspired Technology, and Sanming Project of Medicine in Shenzhen (SZSM202011015)
